BeStock  
Stocks › Biotechnology › SRPT

Sarepta Therapeutics SRPT

US equityMarket cap rank #2908Biotechnology
$13.33 −$0.84 (-5.93%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $13.60 +2.03%
Open$13.92
Prev close$14.17
Day range$13.25 – $14.47
Volume2.25M
Market cap$1.43B
P/E (TTM)–
Dividend yield–

Analyst view

ConsensusHold
Analysts15
Average target$22.33+67.5% vs. price
  • Buy 20%
  • Hold 53%
  • Sell 27%
Low $5.00Now $13.33Avg $22.33High $38.00

Recent rating changes

The last 20 actions on file set price targets from $5.00 to $38.00, averaging $21.26.

DateFirmRatingTarget
13 Nov 2026 Piper Sandler HOLD $20.00
10 Nov 2026 Deutsche Bank HOLD $18.00
9 Nov 2026 Citi SELL $13.00
9 Nov 2026 Barclays HOLD $20.00
6 Nov 2026 Wells Fargo BUY $38.00
6 Nov 2026 Piper Sandler HOLD $20.00
6 Nov 2026 BofA Securities SELL –
6 Nov 2026 Baird HOLD $18.00
6 Nov 2026 Wedbush BUY $35.00
6 Nov 2026 Morgan Stanley HOLD $25.00
6 Nov 2026 H.C. Wainwright SELL $5.00
6 Nov 2026 Oppenheimer BUY $35.00
5 Nov 2026 Cantor Fitzgerald HOLD $21.00
2 Nov 2026 BofA Securities SELL $18.00
30 Oct 2026 H.C. Wainwright SELL $5.00
26 Oct 2026 Wedbush BUY $35.00
19 Oct 2026 Piper Sandler HOLD $20.00
19 Oct 2026 H.C. Wainwright SELL $5.00
16 Oct 2026 Wedbush BUY $35.00
9 Oct 2026 BofA Securities SELL $18.00

Discussion

No comments yet — be the first to weigh in on SRPT.

Sign in to join the discussion.

Scroll to Top